Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility.

Publication ,  Journal Article
Rivera, DR; Gokhale, MN; Reynolds, MW; Andrews, EB; Chun, D; Haynes, K; Jonsson-Funk, ML; Lynch, KE; Lund, JL; Strongman, H; Bhullar, H; Raman, SR
Published in: Pharmacoepidemiol Drug Saf
January 2020

PURPOSE: To provide guidance on data linkage appropriateness and feasibility to plan purposeful and sustainable new linkages that advance pharmacoepidemiology and healthcare research. Planning a new data linkage requires careful evaluation to weigh the resources required with the potential overall benefits. METHODS: In response to an International Society for Pharmacoepidemiology (ISPE) call for manuscripts, a working group comprised of members from academic, industry, and government determined priority content areas; appropriateness and feasibility of data linkage was selected. Within this topic, scientific and operational considerations were determined, reviewed, and formulated into key areas, and translated into 12 consensus recommendations. RESULTS: Guidance for feasibility assessment was categorized into five key areas: (1) research objectives and justification; (2) data quality and completeness; (3) the linkage process; (4) data ownership and governance; and (5) overall value added by linkage. Within these key areas, recommendations to consider prior to initiation were developed to evaluate suitability of the linkage to meet research objectives, assess source data completeness and population coverage, and ensure well-defined data governance standards and protections. When creating novel linked datasets, researchers must assess the feasibility of both scientific (data quality and linkage methods) and operational (access, data use and transfer, governance, and cost) aspects. CONCLUSIONS: The data linkage feasibility assessment considerations outlined can be used as a guide when designing sustainable linked data resources to generate actionable evidence in healthcare research. These recommendations were constructed for wide applicability and can be adapted depending on the geographic, structural, and data components of the linkage.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pharmacoepidemiol Drug Saf

DOI

EISSN

1099-1557

Publication Date

January 2020

Volume

29

Issue

1

Start / End Page

18 / 29

Location

England

Related Subject Headings

  • Research Design
  • Pharmacology & Pharmacy
  • Pharmacoepidemiology
  • Information Storage and Retrieval
  • Humans
  • Feasibility Studies
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rivera, D. R., Gokhale, M. N., Reynolds, M. W., Andrews, E. B., Chun, D., Haynes, K., … Raman, S. R. (2020). Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility. Pharmacoepidemiol Drug Saf, 29(1), 18–29. https://doi.org/10.1002/pds.4918
Rivera, Donna R., Mugdha N. Gokhale, Matthew W. Reynolds, Elizabeth B. Andrews, Danielle Chun, Kevin Haynes, Michele L. Jonsson-Funk, et al. “Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility.Pharmacoepidemiol Drug Saf 29, no. 1 (January 2020): 18–29. https://doi.org/10.1002/pds.4918.
Rivera DR, Gokhale MN, Reynolds MW, Andrews EB, Chun D, Haynes K, et al. Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility. Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):18–29.
Rivera, Donna R., et al. “Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility.Pharmacoepidemiol Drug Saf, vol. 29, no. 1, Jan. 2020, pp. 18–29. Pubmed, doi:10.1002/pds.4918.
Rivera DR, Gokhale MN, Reynolds MW, Andrews EB, Chun D, Haynes K, Jonsson-Funk ML, Lynch KE, Lund JL, Strongman H, Bhullar H, Raman SR. Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility. Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):18–29.

Published In

Pharmacoepidemiol Drug Saf

DOI

EISSN

1099-1557

Publication Date

January 2020

Volume

29

Issue

1

Start / End Page

18 / 29

Location

England

Related Subject Headings

  • Research Design
  • Pharmacology & Pharmacy
  • Pharmacoepidemiology
  • Information Storage and Retrieval
  • Humans
  • Feasibility Studies
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences